To: scion who wrote (4 ) 1/15/2003 4:16:28 PM From: scion Read Replies (1) | Respond to of 6 Dr. David P. Summers serves as our Chief Executive Officer and Chairman. Dr. Summers has served in this capacity on a full-time basis since our inception and is primarily responsible for our operations as a whole. Prior to working with Endovasc, Dr. Summers founded American BioMed, Inc. and served as its President and Chief Executive Officer from 1984 to 1995.Dr. Summers is a Fellow in the American College of Angiology, a Fellow in the International Society for endovascular Surgery, as well as the inventor of several medical devices used to treat cardiovascular diseases. He is the author of 25 issued patents and has 8 patents pending. Prior to founding American BioMed, Dr. Summers assisted with the management of several corporations, including C.R. Bard, Inc., a manufacture and distributor of cardiovascular medical products, Karl Stortz Endoscopy, an endoscopic instrument company, and Pall Corporation, a manufacturer and distributor of blood filtration products. Dr. Summers holds an M.B.A. degree from Pepperdine University as well as a Ph.D. in International Economics from Kennedy-Western University. He is also a member of the New York Academy of Sciences, the American Association of Advancement of Science, the Houston Inventors Association, the European Vascular Society and the Society of Plastic Engineers. 10kwizard.com By the way Davidson leaves an interesting point out of his glowing endorsement of Endovasc. Although Davidson proudly refers to him as "Dr. Summers" in his newsletters, Davidson doesn't tell his subscribers that the Endovasc chief officer got his doctorate degree on the Internet from Kennedy-Western University, a non-accredited university licensed to operate in the state of Wyoming. Summers said Kennedy-Western was accredited in the state of Idaho when he got his degree in 1982. "It wasn't Harvard or Princeton but I learned a lot. I never made any representation other than I got a Ph.d. from Kennedy-Western," the chief officer said. - by Carol S. Remond; Dow Jones News; 201 938 2074; carol.remond@dowjones.com Updated November 20, 2002 3:31 p.m. EST